CLINICAL_TRIALS
trial_result
· 2012-08-16
Clinical Trial Update: Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial [Phase 4]
Summary
Allergan completed the Phase 4 SMART-II trial of Sanctura (trospium chloride) for overactive bladder, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2012-08-16